News Center
Share the latest news with you
2017
2021-06-18
Started PARP Inhibitor IMP4297 (Senaparib) Phase I Study in China and Australia
About Us
News Recommendation
Copyright (c) 2013 IMPACT Therapeutics. All Rights Reserved 沪ICP备2024107649号 互联网药品信息证书编号:(沪)-非经营性-2025-0012 /Clinical Trial Privacy Notice / Privacy Notice / Legal Statement
